Invention Grant
- Patent Title: HX2004-6 polypeptide expressed in cancerous cells
- Patent Title (中): HX2004-6多肽在癌细胞中表达
-
Application No.: US10977087Application Date: 2004-10-28
-
Publication No.: US07867731B2Publication Date: 2011-01-11
- Inventor: Christoph Reinhard , Anne Bennett Jefferson , Vivien W. Chan , Joerg Kaufmann , Hong Xin , Giulia C. Kennedy , Greg Harrowe , Hamiduddin Khoja , Venkatakrishna Shyamala
- Applicant: Christoph Reinhard , Anne Bennett Jefferson , Vivien W. Chan , Joerg Kaufmann , Hong Xin , Giulia C. Kennedy , Greg Harrowe , Hamiduddin Khoja , Venkatakrishna Shyamala
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Mark Seka; Patricia Tsao
- Main IPC: C12P21/00
- IPC: C12P21/00 ; C12P21/02 ; C12N15/09 ; C07K14/00 ; C07K14/435
Abstract:
The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
Public/Granted literature
- US20050130926A1 Gene products differentially expressed in cancerous cells and their methods of use V Public/Granted day:2005-06-16
Information query
